IDEAYA Biosciences, Inc.

IDYA · Nasdaq · SIC 2834: Pharmaceutical Preparations
152
SEC Filings

Business Summary

PART I Item 1. Busi ness. Company Overview We are a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first-in-class targeted therapies aligned to the genetic drivers of disease. We h...

Next Earnings

Q2 FY2026 — expected 2026-09-04

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionIDYAdiscussed_in_filing Cybersecurity
topic_mentionIDYAdiscussed_in_filing Cybersecurity
topic_mentionIDYAdiscussed_in_filing Healthcare & Bio
topic_mentionIDYAdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-172025-12-310001193125-26-054533EDGAR109K words
2025-02-182024-12-310000950170-25-022183EDGAR—
2024-02-202023-12-310000950170-24-017093EDGAR—
2023-03-072022-12-310000950170-23-006456EDGAR—
2022-03-182021-12-310001564590-22-010922EDGAR—
2021-03-232020-12-310001564590-21-014676EDGAR—
2020-03-242019-12-310001564590-20-012501EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-264632EDGAR26K words
2025-08-052025-06-300000950170-25-102967EDGAR—
2025-05-062025-03-310000950170-25-064438EDGAR—
2024-11-042024-09-300000950170-24-120675EDGAR—
2024-08-062024-06-300000950170-24-091823EDGAR—
2024-05-072024-03-310000950170-24-054466EDGAR—
2023-11-072023-09-300000950170-23-060206EDGAR—
2023-08-102023-06-300000950170-23-041394EDGAR—
2023-05-092023-03-310000950170-23-019605EDGAR—
2022-11-082022-09-300000950170-22-023207EDGAR—
2022-08-152022-06-300000950170-22-017204EDGAR—
2022-05-102022-03-310000950170-22-008946EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-170001193125-26-052741EDGAR2K words
2026-01-120001193125-26-009653EDGAR—
2026-01-120001193125-26-009641EDGAR—
2025-12-120001193125-25-317541EDGAR—
2025-12-050001193125-25-309716EDGAR—
2025-11-040001193125-25-263383EDGAR—
2025-10-200001193125-25-243558EDGAR—
2025-09-080001193125-25-197605EDGAR—
2025-09-020001193125-25-193238EDGAR—
2025-08-050000950170-25-102353EDGAR—

152 total filings indexed. 123 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001676725
TickerIDYA
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 018ab17c977ca1e59b4a8166d564449756b7579102528ed4e5d2030a892cb889
parent: 9cdb882600289adc52927e1c25acb4200eb4b47335226f9f75a48dae45ab919a
content hash: dcc1dde96da1c99c66d57b8be74d38e03c7a900234bbcf3f7ee2877a037a92ba
signed: 2026-04-13T04:45:38.272Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf